Effect of mizoribine on pulmonary lesions in MRL/lpr/lpr mice

Autoimmunity

Volumn 25, Issue 1, 1996, Pages 9-18

  Soga, Takayoshi ^a   Ishigatsubo, Yoshiaki ^a   Kitamura, Hitoshi ^a   Okubo, Takao ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Mizoribine; MRL lpr lpr; Pulmonary lesions

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; MIZORIBINE; SMALL NUCLEAR RNA; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; IMMUNOGLOBULIN PRODUCTION; LUNG INJURY; LYMPHOCYTIC INFILTRATION; MOUSE; MOUSE STRAIN; NONHUMAN;

EID: 0030431597     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939608994722     Document Type: Article

References (47)

1. Hunninghake, G. W., Fauci, A. S. State of the art: Pulmonary involvement in the collagen vascular diseases. Am. Rev Respir. Dis 1979; 119: 472-503.
2. Matthay, R. A., Schwartz, M. I., Petty, T. L., Standord, R. E., Gupta, R. C., Sahn, S. A. et al. Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine. 1974; 54: 397-409.
3. Haupt, H. M., Moore, G. W., Hutchins, G. M. The lung in systemic lupus erythematosus analysis of the pathologic changes in 120 patients. Am. J. Med. 1981; 71: 792-798.
4. Andrews, B. S., Eisenberg, R. A., Theofilopoulos, A. N., Izui, S., Wilson, C. B., McConahey, P. J. et al. Spontaneous murine lupus-like syndromes. J. Exp. Med. 1978; 148: 1198-1215.
5. Isenberg, D. A., Snaith, M. L., Morrow, J. W., Al-Khander, A. A., Cohen, S. L., Fisher, C. et al. Cyclosporin A for the treatment of systemic lupus erythematosus. Int. J. Immunopharmacol 1981; 3: 163-169.
6. Smith, H. R., Chused, T. M., Steinberg, A. D. Cyclophosphamide induced changes in the MRL-lpr/lpr mouse: effect upon cellular composition, immune function and disease. Clin. Immunol. Immunopathol. 1984; 30: 51-61.
7. Okudaira, H., Ogita, T., Miyamoto, T., Shiga, J., Suko, M., Okudaira, K. et al. Interstitial pneumonitis in autoimmune MRL/lpr mice and its treatment with cyclosporin A. Clin. Immunol. Immunopathol. 1986 38: 47-54.
8. Mountz, J. D., Smith, H. R., Wilder, R. L., Reeves, J. P., Steinberg, A. D. CsA therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production. J. Immunol. 1987; 138: 157-163.
9. Takabayashi, K., Koike, T., Kurasawa, K., Matsumura, R., Sato, T., Tomioka, H. et al. Effect of FK506, a novel immunosuppressive drug on murine systemic lupus erythematosus. Clin. Immunol. Immunopathol. 1989; 51: 110-117.
10. Yamamoto, K., Mori, A., Nakahama, T., Ito, M., Okudaira, H., Miyamoto, T. Experimental treatment of autoimmune MRL-lpr/lpr mice with immunosuppressive compound FK506. Immunology 1990; 69: 222-227.
11. Mizuno, K., Tsujino, M., Takada, M., Hayashi, M., Atsumi, K., Asano, K. et al. Studies on bredinin, I. Isolation, characterization and biological properties. J. Antibiol. 1974; 27: 775-782.
12. Sakaguchi, K., Tsujino, M., Mizuno, K., Kayano, K. Action of bredinin on mammalian cells. Cancer Res. 1975; 35: 1643-1648.
13. Okubo, M., Chem, X. M., Kamata, K., Masaki, Y., Uchiyama, T. Suppressive effect of mizoribine on humoral antibody production in DBA/2 mice. Transplantalion 1986; 41: 495-498.
14. Weibel, E. R. Stereological principles for morphometry in electron microscopy. Int. Rev. Cytol. 1969; 26: 235-302.
15. Gundersen, H. J. G., Boysen, M., Reith, A. Comparison of semiautomatic digitizer-tablet and simple point counting performance in morphometry. Virchows Arch. B 1981; 37: 317-325.
16. Williams, D. A., Forgaty, K. E., Tsien, R. Y., Fay, F. S. Calcium gradients in single smooth muscle cells revealed by the digital imaging microscope using fura-2. Nature 1985; 318: 558-561.
17. Ando, D. G., Ebling, F. M., Ham, B. H. Detection of native and denatured DNA antibody forming cells by the enzyme-linked immunospot assay. Arthritis Rheum. 1986; 29: 1139-1146.
18. Sedwick, J. D., Holt, P. G. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J. Immunol. Methods 1983; 57: 301-309.
19. Klinman, D. M., Steinberg, A. D. Systemic autoimmune disease arises from polyclonal B cell activation. J. Exp. Med. 1987; 165: 1755-1760.
20. Kamata, K., Okubo, M., Ishigamori, E., Masaki, Y., Uchida, H., Watanabe, K. et al. Immunosuppressive effect of bredinin on cell-mediated and humoral immune reactions in experimental animals. Transplantation 1983; 35: 144-149.
21. Koyama, H., Tsuji, M. Genetic and biochemical studies on the activation and cytotoxic mechanism of bredinin a potent inhibitor of purine biosynthesis in mammalian cells. Biochem. Pharmacol. 1983; 32: 3547-3553.
22. Turka, L. A., Dayton, J., Sinclair, G., Thompson, C. B., Mitchell, B. S. Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of immunosuppressive drug mizoribine. J. Clin. Invest. 1991; 87: 940-948.
23. Kobayashi, Y., Shigematsu, H., Masaki, Y. Modification of crescentic masugi nephritis in the rabbit by bredinin, a new immunosuppressant. Virchows Arch. B 1983; 43: 103-119.
24. Okamoto, K., Ito, M., Suzuki, Y. Studies on antinephritic effect of mizoribine (p-INN, bredinin), a new immunosuppressive agent, and azathioprine (1). Effect on the nephrotic type of anti-GBM nephritis in rats. Japan J. Pharmacol. 1983; 33: 541-548.
25. Okamoto, K., Ito, M., Suzuki, Y. Studies on antinephritic effect of mizoribine (p-INN, bredinin), a new immunosuppressive agent, and azathioprine (2). Effect on crescentic-type anti-GBM nephritis in rats. Japan. J. Pharmacol. 1984; 34: 33-41.
26. Kamata, K., Okubo, M., Uchiyama, T., Masaki, Y., Kobayashi, Y., Tanaka, T. Effect of mizoribine on lupus nephropathy of New Zealand black/white F1 hybrid mice. Clin. Immunol. Immunopathol. 1984; 33: 31-38.
27. Sunderrajan, E. V., Mckenzie, W. N., Lieske, T. R., Kavanaugh, J. L., Braun, S. R., Walker, S. E. Pulmonary inflammation in autoimmune MRL/MP-lpr/lpr mice; Histopathology and bronchoalveolar lavage evaluation. Am. J. Pathol. 1986; 124: 353-362.
28. Moyer, C. F., Strandberg, J. D., Reinish, C. L. Systemic mononuclear-cell vasculitis in MRL/MP-lpr/lpr mice: A histologic and immunocytochemical analysis. Am. J. Pathol 1987; 127: 229-242.
29. Ebling, F., Hahn, B. H. Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus. Arthritis Rheum. 1980; 23: 392-403.
30. Nardella, F. A., Teller, D. C., Izui, S., Mannik, M. Self-associating IgG-rheumatoid factors in MRL/I autoimmune mice. Arthritis Rheum. 1984; 27: 1165-1173.
31. Izui, S., Elder, J. H., McConahey, P. J., Dixon, F. J. Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus. J. Exp. Med. 1979; 149: 1099-1116.
32. Pertschuk, L. P., Moccia, L. A., Rosen, Y., Lyons, H., Marino, C. M., Rashford, A. A. et al. Acute pulmonary-complications in systemic lupus erythematosus: immuonofluorescence and light microscopic study. Am. J. Clin. Pathol. 1977; 68: 553-557.
33. Brentjcns, J., Ossi, E., Albini, B., Sepulveda, M., Kano, K., Sheffer, J. et al. Disseminated immune deposits in lupus erythematosus. Arthritis Rheum. 1977; 20: 962-968.
34. Rodriguez-Iturbe, B., Garcia, R., Rubio, L., Serrano, H. Immunohistologic findings in the lung in systemic lupus erythematosus. Arch. Pathol. Lab. Med. 1977; 101: 342-344.
35. Eagen, J. W., Roberts, J. L., Schwartz, M. M., Lewis, E. J. The composition of pulmonary immune deposits in systemic lupus erythematosus. Clin Immunol. Immunopathol. 1979; 12: 204-219.
36. Inoue, T., Kanayama, Y., Ohe, A., Kato, N., Horiguchi, T., Ishii, M. et al. Immunopathologic studies of pneumonitis in systemic lupus erythematosus. Ann. Intern. Med. 1979; 91: 30-34.
37. Schwab, E. P., Schumacher, H. R. Jr, Freundlich, B., Callegari, P. E. Pulmonary alveolar hemorrhage in systemic lupus erythematosus. Semin. Arthritis Rheum. 1993; 23: 8-15.
38. Kinney, W. W., Angelillo, V. A. Bronchiolitis in systemic lupus erythematosus. Chest 1982; 82: 646-649.
39. Lewis, D. E., Giorgi, J. V., Warner, N. L. Flow cytometry analysis of T cells and continuous T cell lines from autoimmune MRL/1 mice. Nature 1981; 289: 298-300.
40. Theofilopoulos, A. N., Eisenberg, R. A., Bourdon, M., Crowell, J. S., Dixon, F. J. Distribution of lymphocytes identified by surface markers in murine strains with systemic lupus erythematosus-like syndromes. J. Exp. Med. 1979; 149: 516-534.
41. Alexander, E. L., Moyer, C., Travlos, G. S., Roths, J. B., Murphy, E. D. Two histopathologic types of inflammatory vascular disease in MRL/Mp autoimmune mice: Model for human vasculitis in connective tissue disease. Arthritis Rheum. 1985; 28: 1146-1155.
42. + T cells to lymphoproliferation and autoantibody production in MRL/lpr mice. J. Exp. Med. 1988; 167: 1713-1718.
43. O'Sullivan, F. X., Ray, C. J., Takeda, Y., Sharp, G. C., Walker, S. E. Long-term anti-CD4 treatment of MRL/ lpr mice ameliorates immunopathology and lymphoproliferation but fails to suppress rheumatoid factor production. Clin, Immunol. Immunopathol. 1991; 61: 421-435.
44. Gilkeson, G. S., Spurney, R., Coffman, T. M., Kurlander, R., Ruiz, P., Pisetsky, D. S. Effect of antiCD4 antibody treatment on inflammatory arthritis in MRL/lpr mice. Arthritis Rheum. 1992; 64: 166-172.
45. Jabs, D. A., Burek, C. L., Hu, Q., Kuppers, R. C., Lee, B., Prendergast, R. A. Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice. Cell. Immunol 1992; 141: 496-507.
46. Jabs, D. A., Kuppers, R. C., Saboori, A. M., Burek, C. L., Enger. C., Lee, B. et al. Effects of early and late treatment with anti-CD4 monoclonal antibody on autoimmune disease in MRL/Mp-lpr/lpr mice. Cell Immunol. 1994; 154: 66-76.
47. Tomer, Y., Blank, M., Shoenfeld, Y. Suppression of experimental antiphospholipid syndrome and systemic lupus erythcmatosus in mice by anti-CD4 monoclonal antibodies. Arthritis Rheum. 1994; 37: 1236-1244.